#1 Insulin Resistance
Probiotics and Synbiotics → Insulin Resistance
- EvidenceScore™
- 84
- Strong
- ImpactScore™
- 70
- Positive
- ConsistencyScore™
- 60
- generally_consistent
Metabolic Health has evidence across 10 diabetes-related interventions, with strongest support for Probiotics and Synbiotics, Insulin Therapies and Probiotics and Synbiotics.
Evidence Intelligence™
Every evidence topic is generated from structured relationships across diabetes research, including topics, interventions, outcomes, and individual studies.
| Rank | Intervention group | Outcome group | EvidenceScore™ | ImpactScore™ | Consistency | Studies | Effectiveness | Action |
|---|---|---|---|---|---|---|---|---|
| #1 | Probiotics and Synbiotics | Insulin Resistance | 84/100Strong | 70/100Positive | 60/100generally_consistent | 5 | moderate_positive | Explore evidence |
| #2 | Insulin Therapies | Insulin Resistance | 83/100Strong | 90/100Very Positive | 100/100consistent | 5 | strong_positive | Explore evidence |
| #3 | Probiotics and Synbiotics | Adipokine and Angiogenic Markers | 83/100Strong | 70/100Positive | 56/100generally_consistent | 10 | moderate_positive | Explore evidence |
| #4 | Metformin Therapies | Insulin Resistance | 82/100Strong | 71/100Positive | 60/100generally_consistent | 5 | moderate_positive | Explore evidence |
| #5 | GLP-1 Receptor Agonists | Adipokine and Angiogenic Markers | 81/100Strong | 85/100Very Positive | 86/100consistent | 7 | strong_positive | Explore evidence |
| #6 | Diabetes Self-Management Education and Support (DSMES) Programs | Blood Pressure | 81/100Strong | 71/100Positive | 60/100generally_consistent | 5 | moderate_positive | Explore evidence |
| #7 | GLP-1 Receptor Agonists | Insulin Resistance | 80/100Strong | 90/100Very Positive | 80/100consistent | 5 | strong_positive | Explore evidence |
| #8 | GLP-1 Receptor Agonists | Blood Pressure | 80/100Strong | 79/100Positive | 88/100consistent | 9 | moderate_positive | Explore evidence |
| #9 | Diabetes Self-Management Education and Support (DSMES) Programs | Adipokine and Angiogenic Markers | 80/100Strong | 73/100Positive | 80/100consistent | 7 | moderate_positive | Explore evidence |
| #10 | Insulin Delivery Systems | Insulin Resistance | 79/100Strong | 43/100Slightly Negative | 67/100generally_consistent | 3 | weak_negative | Explore evidence |
Probiotics and Synbiotics → Insulin Resistance
Insulin Therapies → Insulin Resistance
Probiotics and Synbiotics → Adipokine and Angiogenic Markers
Metformin Therapies → Insulin Resistance
GLP-1 Receptor Agonists → Adipokine and Angiogenic Markers
Diabetes Self-Management Education and Support (DSMES) Programs → Blood Pressure
GLP-1 Receptor Agonists → Insulin Resistance
GLP-1 Receptor Agonists → Blood Pressure
Diabetes Self-Management Education and Support (DSMES) Programs → Adipokine and Angiogenic Markers
Insulin Delivery Systems → Insulin Resistance
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
Vitamin D supplementation have the strongest available evidence signals for Metabolic Health.
ConsistencyScore™: Results are consistent across studies.
Ranked evidence signals
Vitamin D supplementation
EvidenceScore™ Strong | EvidenceScore™ 80.4 | strong positive | ConsistencyScore™ Consistent | 9 studies
Why this answer: This answer is cautious because the available studies report mixed findings.
Limitations
Dapagliflozin, Metformin, and Vitamin D supplementation are among the most studied areas in relation to Metabolic Health.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Vitamin D supplementation
EvidenceScore™ Strong | EvidenceScore™ 80.4 | strong positive | ConsistencyScore™ Consistent | 17 studies
Dapagliflozin
EvidenceScore™ Moderate | EvidenceScore™ 69.0 | moderate positive | ConsistencyScore™ Mixed | 5 studies
Metformin
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 5 studies
Why this answer: This answer is cautious because the available studies report mixed findings.
Limitations
Results are mixed or unclear for Dapagliflozin, Exercise therapy, and Multi-species synbiotic (12 probiotic strains + FOS prebiotic) in relation to Metabolic Health.
ConsistencyScore™: Results are mixed and should be interpreted cautiously.
Ranked evidence signals
Vitamin D supplementation
EvidenceScore™ Strong | EvidenceScore™ 79.0 | weak positive | ConsistencyScore™ Mixed | 6 studies
Dapagliflozin
EvidenceScore™ Moderate | EvidenceScore™ 69.0 | moderate positive | ConsistencyScore™ Mixed | 2 studies
Multi-species synbiotic (12 probiotic strains + FOS prebiotic)
EvidenceScore™ Moderate | EvidenceScore™ 69.0 | moderate positive | ConsistencyScore™ Mixed | 2 studies
Why this answer: This answer is cautious because the available studies report mixed findings.
Applicability
Population details were available for 2 of 18 supporting studies. Reported populations varied; examples included 78-year-old man with 40-year T2D history, 31 years insulin-dependent, sarcopenic obesity, extensive cardiovascular disease history, moderate glycemic control (HbA1c 7.0%) and Adults with T2D in India, most using oral medications, with median HbA1c 7.5% and median BMI 27.0 kg/m2.
whey protein 20g need more research in relation to Metabolic Health.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
whey protein 20g
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Vitamin D supplementation have available evidence for Metabolic Health, but the comparison requires review of the underlying studies.
ConsistencyScore™: Results are consistent across studies.
Ranked evidence signals
Vitamin D supplementation
EvidenceScore™ Strong | EvidenceScore™ 80.4 | strong positive | ConsistencyScore™ Consistent | 9 studies
Why this answer: This answer is based on 9 supporting studies with consistent results and a positive effect signal.
Limitations
Intervention categories most commonly studied for metabolic health outcomes.
Evidence related to GLP-1 receptor agonist therapies in diabetes studies.
Evidence related to probiotic and synbiotic interventions in diabetes studies.
Evidence related to metformin therapies in diabetes studies.
Evidence related to aerobic exercise interventions in diabetes studies.
Evidence related to DPP-4 inhibitor therapies in diabetes studies.
Evidence related to alpha-glucosidase inhibitor therapies in diabetes studies.
Each bubble represents an evidence relationship. Position shows effectiveness and EvidenceScoreâ„¢; size reflects study volume.
Evidence Workspace
Save evidence topics and organize the research that matters to you.